Angiogenic factors and their role in pathogenesis and prediction of preeclampsia;Angiogene faktoren und ihre rolle in der entstehung und vorhersage der präeklampsie

Seminars in Speech and Language

Volumn 30, Issue 2, 2009, Pages 101-105

  Stepan, Holger ^a   Jank, A ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Angiogenic factors; PlGF; Predictive value; Preeclampsia; sEng; sFlt1

Indexed keywords

ANGIOGENIC PROTEIN;

BIOLOGICAL MODEL; FEMALE; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PLACENTA CIRCULATION; PREECLAMPSIA; PREGNANCY; REVIEW;

ANGIOGENIC PROTEINS; FEMALE; HUMANS; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PATHOLOGIC; PLACENTAL CIRCULATION; PRE-ECLAMPSIA; PREGNANCY;

EID: 77149156609     PISSN: 07340478     EISSN: 10989056     Source Type: Journal    
DOI: 10.1055/s-0029-1224142     Document Type: Review

References (31)

1. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 365: 785-799
2. Roberts JM, Pearson GD, Cutler JA et al. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertens Pregnancy 2003; 22: 109-127
3. Conde-Agudelo A, Villar J, Lindheimer M. World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol 2004; 104 (6): 1367-1391
4. Chien PF, Arnott N, Gordon A et al. How useful is uterine artery Doppler flow velocimetry in the prediction of pre-eclampsia, intrauterine growth retardation and perinatal death? An overview. Brit J Obstet Gynaecol 2000; 107: 196-208
5. Martin AM, Bindra R, Curcio P et al. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation. Ultrasound Obstet Gynecol 2001; 18: 583-586
6. Benedetto C, Valensise H, Marozio L et al. A two-stage screening test for pregnancy-induced hypertension and preeclampsia . Obstet Gynecol 1998; 92: 1005-1011
7. Lam C, Lim KH, Karumanchi SA . Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia . Hypertension 2005; 46: 1077-1085
8. Levine RJ, Karumanchi SA. Circulating angiogenic factors in preeclampsia. Clin Obstet Gynecol 2005; 48: 372-386
9. Tjoa ML, Levine RJ, Karumanchi SA. Angiogenic factors and preeclampsia. Front Biosci 2007; 12: 2395-2402
10. Maynard SE, Min JY, Merchan J et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649-658
11. Venkatesha S, Toporsian M, Lam C et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006; 12: 642-649
12. Levine RJ, Maynard SE, Qian C et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672-683
13. Hertig A, Berkane N, Lefevre G et al. Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia . Clin Chem 2004; 50: 1702-1703
14. Taylor RN, Grimwood J, Taylor RS et al. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathological pregnancies. Am J Obstet Gynecol 2003; 188: 177-182
15. Tidwell SC, Ho HN, Chiu WH et al. Low maternal serum levels of placental growth factor as an antecedent of clinical preeclampsia . Am J Obstet Gynecol 2001; 184: 1267-1272
16. Thadhani R, Mutter WP, Wolf M et al. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 2004; 89: 770-775
17. Tsatsaris V, Go. n F, Munaut C et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab 2003; 88: 5555-5563
18. Stepan H, Geide A, Faber R. Soluble fms-like tyrosine kinase 1. N Engl J Med 2004; 351: 2241-2242
19. Stepan H, Unversucht A, Wessel N et al. Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. Hypertension 2007; 49: 818-824
20. Crispi F, Dominquez C, Llurba E et al. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol 2006; 195: 201-207
21. Romero R, Nien JK, Espinoza J et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008; 21: 9-23
22. Levine RJ, Lam C, Qian C et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia . N Engl J Med 2006; 355: 992-1005
23. Stepan H, Krämer T, Faber R . Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction . J Clin Endocrinol Metabol 2007; 92: 2831-2834
24. Stepan H, Geipel A, Schwarz F et al. Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion. Am J Obstet Gynecol 2008; 198, 175 e171-176
25. Nagamatsu T, Fujii T, Kusumi M et al. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 2004; 145 (11): 4838-4845
26. Karumanchi SA, Bdolah Y . Hypoxia and sFlt-1 in preeclampsia: the " chick en-and-egg " question. Endocrinology 2004; 145 (11): 4835-4837
27. Bdolah Y, Lam C, Rajakumar A et al. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia? Am J Obstet Gynecol 2008; 198 (4): 428 e1-6
28. Rana S, Venkatesha S, DePaepe M et al. Cytomegalovirus-induced mirror syndrome associated with elevated levels of angiogenic factors . Obstet Gynecol 2007; 109: 549-552
29. Stepan H, Faber R. Cytomegalovirus-induced mirror syndrome associated with elevated levels of angiogenic factors. Obstet Gynecol 2007; 109: 1205-1206
30. Espinoza J, Romero R, Nien JK et al. A role of the anti-angiogenic factor sVEGFR-1 in the ' mirror syndrome ' (Ballantyne's syndrome). J Matern Fetal Neonatal Med 2006; 19 (10): 607-613
31. Stepan H, Faber R . Elevated sFlt1 level and preeclampsia with parvovirus-induced hydrops . N Engl J Med 2006; 354: 1857-1858